Form 4: Brainsway Ltd. Insider Sells Shares
Statement of Changes in Beneficial Ownership
Brainsway Ltd. Chief Scientist Yiftach Roth reported transactions involving the sale of ordinary shares.
Summary
- Yiftach Roth, Chief Scientist at Brainsway Ltd., reported several transactions on June 1st and June 2nd, 2026.
- These transactions involved the sale of ordinary shares.
- On June 1st, 2026, Roth sold 2,000 shares at NIS 43.64 and another 2,000 shares at NIS 43.45.
- Following these sales, Roth beneficially owned 1,075,305 shares.
- On June 2nd, 2026, Roth sold 1,000 shares at NIS 43 and 2,000 shares at NIS 42.0035.
- After all reported transactions, Roth beneficially owns 1,072,305 shares.
- The reported ownership includes shares held jointly with his spouse, 15,000 ordinary shares, and unvested restricted stock units (RSUs) for 5,000 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions without providing new financial information or strategic insights, thus having a limited immediate impact on sentiment.
Negatives
- Insider selling activity by a key executive (Chief Scientist) can sometimes be perceived negatively by the market, although the reasons for the sale are not specified.
Risks
- The filing does not explicitly mention any risks. However, insider selling can sometimes signal a lack of confidence in future stock performance, though this is not always the case.
Future Outlook
The filing does not contain forward-looking statements or guidance. It is a report of past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The sale of shares by a Chief Scientist at Brainsway Ltd. is a routine event that provides transparency regarding executive holdings but does not inherently signal a change in the company's strategic direction or financial health.
Stakeholder Impact
- Shareholders: May observe insider selling, which can sometimes lead to short-term price fluctuations or questions about management's confidence, though the reasons for the sale are not provided.
- Employees: The transactions do not directly impact employee compensation or roles, but insider activity can influence overall employee morale.
- Creditors: No direct impact is expected as the filing concerns equity transactions.
- Suppliers/Customers: No direct impact is expected.
Next Steps
- Continue to monitor future SEC filings for any further transactions by company insiders.
- Analyze the company's financial performance and strategic updates in subsequent filings.
Key Dates
| Date | Description |
|---|---|
| 06/01/2026 | Earliest transaction date reported and date of initial share sales. |
| 06/02/2026 | Date of additional share sales. |
| 06/03/2026 | Date of signature on the filing. |
Keywords
Brainsway Ltd., BWAY, Form 4, Insider Trading, Stock Sale, Beneficial Ownership, Yiftach Roth, Chief Scientist, Ordinary Shares, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.